The natural history of EGFR and EGFRvIII in glioblastoma patients

[1] Kallio M(1991)A population-based study on the incidence and survival rates of 3857 glioma patients diagnosed from 1953 to 1984 Cancer 68 1394-1400

[2] Sankila R(1998)Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973-1991 J Neurosurg 88 1-10

[3] Jaaskelainen J(1993)Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials J Natl Cancer Inst 85 704-710

[4] Karjalainen S(2001)A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival J Neurosurg 95 190-198

[5] Hakulinen T(1989)Supratentorial anaplastic gliomas in adults. The prognostic importance of extent of resection and prior low-grade glioma J Neurosurg 71 487-493

[6] Davis FG(1991)Genes for epidermal growth factor receptor, transforming growth factor alpha, and epidermal growth factor and their expression in human gliomas in vivo Cancer Res 51 2164-2172

[7] Freels S(1997)Cell surface localization and density of the tumor-associated variant of the epidermal growth factor receptor, EGFRvIII Cancer Res 57 4130-4140

[8] Grutsch J(1994)Functional characterization of an EGF receptor with a truncated extracellular domain expressed in glioblastomas with EGFR gene amplification Oncogene 9 2313-2320

[9] Barlas S(2004)Immunohistochemical detection of EGFRvIII in high malignancy grade astrocytomas and evaluation of prognostic significance J Neuropathol Exp Neurol 63 700-707

[10] Brem S(1998)Gene amplification as a prognostic factor in primary and secondary high-grade malignant gliomas Int J Oncol 13 717-724

[1] Kallio M(1991)A population-based study on the incidence and survival rates of 3857 glioma patients diagnosed from 1953 to 1984 Cancer 68 1394-1400

[2] Sankila R(1998)Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973-1991 J Neurosurg 88 1-10

[3] Jaaskelainen J(1993)Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials J Natl Cancer Inst 85 704-710

[4] Karjalainen S(2001)A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival J Neurosurg 95 190-198

[5] Hakulinen T(1989)Supratentorial anaplastic gliomas in adults. The prognostic importance of extent of resection and prior low-grade glioma J Neurosurg 71 487-493

[6] Davis FG(1991)Genes for epidermal growth factor receptor, transforming growth factor alpha, and epidermal growth factor and their expression in human gliomas in vivo Cancer Res 51 2164-2172

[7] Freels S(1997)Cell surface localization and density of the tumor-associated variant of the epidermal growth factor receptor, EGFRvIII Cancer Res 57 4130-4140

[8] Grutsch J(1994)Functional characterization of an EGF receptor with a truncated extracellular domain expressed in glioblastomas with EGFR gene amplification Oncogene 9 2313-2320

[9] Barlas S(2004)Immunohistochemical detection of EGFRvIII in high malignancy grade astrocytomas and evaluation of prognostic significance J Neuropathol Exp Neurol 63 700-707

[10] Brem S(1998)Gene amplification as a prognostic factor in primary and secondary high-grade malignant gliomas Int J Oncol 13 717-724